Clinical Trial Update: Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating chemotherapy with or without isolated hepatic perfusion using melphalan for colorectal cancer that has metastasized to the liver; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Alkeran (melphalan)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 3 | Status: COMPLETED